FR2073436A1 - - Google Patents

Info

Publication number
FR2073436A1
FR2073436A1 FR7042991A FR7042991A FR2073436A1 FR 2073436 A1 FR2073436 A1 FR 2073436A1 FR 7042991 A FR7042991 A FR 7042991A FR 7042991 A FR7042991 A FR 7042991A FR 2073436 A1 FR2073436 A1 FR 2073436A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7042991A
Other languages
French (fr)
Other versions
FR2073436B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2073436A1 publication Critical patent/FR2073436A1/fr
Application granted granted Critical
Publication of FR2073436B1 publication Critical patent/FR2073436B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7042991A 1969-11-29 1970-11-30 Expired FR2073436B1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9581969 1969-11-29

Publications (2)

Publication Number Publication Date
FR2073436A1 true FR2073436A1 (da) 1971-10-01
FR2073436B1 FR2073436B1 (da) 1974-08-30

Family

ID=14148007

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7042991A Expired FR2073436B1 (da) 1969-11-29 1970-11-30

Country Status (7)

Country Link
CA (1) CA962593A (da)
DE (1) DE2058645C2 (da)
DK (1) DK124340B (da)
ES (1) ES385968A1 (da)
FR (1) FR2073436B1 (da)
GB (1) GB1274820A (da)
NL (1) NL170595C (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
ES2619936T3 (es) 2004-11-05 2017-06-27 Wellstat Biologics Corporation Formulaciones de virus envueltos estables y filtrables
CN102268410B (zh) * 2011-06-17 2013-02-27 湖北省农业科学院畜牧兽医研究所 一株适应幼仓鼠肾传代细胞的新城疫病毒耐热弱毒株及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1010509A (en) * 1962-02-23 1965-11-17 Pfizer Ltd Improvements in or relating to newcastle disease virus vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1010509A (en) * 1962-02-23 1965-11-17 Pfizer Ltd Improvements in or relating to newcastle disease virus vaccines

Also Published As

Publication number Publication date
ES385968A1 (es) 1973-11-16
NL7017334A (da) 1971-06-02
GB1274820A (en) 1972-05-17
NL170595C (nl) 1982-12-01
NL170595B (nl) 1982-07-01
CA962593A (en) 1975-02-11
DK124340B (da) 1972-10-09
FR2073436B1 (da) 1974-08-30
DE2058645A1 (de) 1971-06-09
DE2058645C2 (de) 1982-02-11

Similar Documents

Publication Publication Date Title
AU465413B2 (da)
AU4221168A (da)
AU5461069A (da)
FR2073436B1 (da)
AU442375B2 (da)
AU470301B1 (da)
AU427401B2 (da)
AU425297B2 (da)
AU442535B2 (da)
AU410358B2 (da)
AU442538B2 (da)
AU442322B2 (da)
AT308690B (da)
AU417208B2 (da)
AU470661B1 (da)
AU442380B2 (da)
AU414607B2 (da)
AU442357B2 (da)
AU5079269A (da)
AU4923469A (da)
AU5077469A (da)
AU5109569A (da)
AU5598769A (da)
AR203167Q (da)
AU4953367A (da)

Legal Events

Date Code Title Description
ST Notification of lapse